Skip to content

Time Restricted Feeding, Muscle, and Metabolism

Time Restricted Feeding Intervention for Muscle and Metabolic Health (TRIMM)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04949451
Acronym
TRIMM
Enrollment
90
Registered
2021-07-02
Start date
2021-06-13
Completion date
2025-12-30
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Brief summary

Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not emerged. This study uses time restricted feeding to study the role of dietary protein in obesity prevention and/or treatment. The objectives are to determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and peripheral signals that regulate appetite and energy intake in overweight and obese adults and to determine the effects of protein timing on muscle mass to regulate appetite and energy intake in overweight and obese adults.

Interventions

DIETARY_SUPPLEMENTKetogenic aid

Participants consume ketogenic aid upon waking.

OTHERControl group - time restricted feeding only

Time restricted feeding.

DIETARY_SUPPLEMENTWhey protein supplement

Participants consume whey protein at the beginning of the eating period.

Sponsors

University of Arkansas, Fayetteville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Resides in Northwest Arkansas * Age 25-50 years * BMI \> 25 * All ethnicities * Female and male

Exclusion criteria

* Food allergies * Pregnant or breastfeeding * Dietary restrictions (e.g. vegetarian, vegan, etc.) * Trying to lose weight in last 3 months * Pre-existing health conditions related to obesity (e.g. cardiovascular disease, diabetes, hypertension) * Prescription medications related to heart disease or type 2 diabetes * Fear of needles * Smoker or vaping * Currently taking protein supplements or other nutritional supplements which may interfere with study outcomes * Consumes \>4 alcoholic beverages per week

Design outcomes

Primary

MeasureTime frameDescription
Body compositionChange is being assessed at baseline and final day (day 120) of the intervention.Body composition measured using dual x-ray absorptiometry to determine the ration of lean/fat-free mass to fat mass.

Secondary

MeasureTime frameDescription
Muscle massChange is being assessed at baseline and final day (day 120) of the intervention.Muscle mass will be measured using D3-creatine
Body weightChange is being assessed at baseline, 4, 8, and 12 weeks.Body weight will be measured in kilograms.
SleepChange is being assessed at baseline and 12 weeksSleep will be assessed using wrist Actigraphy for sleep duration and total time in bed.
Sleep QualityChange is being assessed at baseline, 4, 8, and 12 weeksSleep quality will be measured using the Pittsburgh Sleep Quality Index survey
MoodChange is being assessed at baseline, 4, 8, and 12 weeksMood will be assessed using the Profile of Mood States Questionnaire
Whole body protein turnoverChange is being assessed at baseline and final day (day 120) of the intervention.Whole body protein turnover will be measured using 15N-alanine
Self-reported physical activityChange is being assessed at baseline, 4, 8, and 12 weeksPhysical activity will be measured using the iPAQ survey
Dietary intakeChange is being assessed at baseline, 4, 8, and 12 weeksDietary intake will be measured using weighed, 3-day food records
Fasting glucoseChange is being assessed at baseline, 4, 8, and 12 weeksGlucose will be measured as mg/dl
Hand gripChange is being assessed at baseline, 4, 8, and 12 weeksHand grip will be measured using a dynamometer.
Amino acids and metabolitesChange is being assessed at baseline, 4, 8, and 12 weeksBlood will be collected and plasma amino acids and metabolites will be assessed using commercially available kit for amino acid analysis for all circulating amino acids.
GritChange is being assessed at baseline, 4, 8, and 12 weeksGrit will be assessed using the grit questionnaire.

Countries

United States

Contacts

Primary ContactJamie Baum, PhD
baum@uark.edu479-575-4474

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026